Paper 47 - EPIGENETIC AGE ACCELERATION IS A DISTINCTIVE TRAIT OF EPITHELIOID SARCOMA WITH POTENTIAL THERAPEUTIC IMPLICATIONS

Author(s)

• 

  Simon Haefliger, MD

  Associate fellow
  University College London, Cancer Institute
  London, England, United Kingdom

  Slides

Co-Author(s)

• OC

  Olga Chervova, PhD

  Medical Genomics Research Group, University College London, UCL Cancer Institute, London, UK
  London, England, United Kingdom
• 

  Christopher Davies, MSci

  Research Technician
  University College London, Cancer Institute
  London, England, United Kingdom
• CL

  Chet Loh, PhD

  Altos Labs, Cambridge Institute of Science, Cambridge, UK
  Cambridge, England, United Kingdom
• RT

  Roberto Tirabosco, MD

  Consultant
  Department of Histopathology, Royal National Orthopaedic Hospital, Stanmore, UK
  London, England, United Kingdom
• 

  Fernanda Amary, MD-PhD

  Consultant Pathologist
  Department of Histopathology, Royal National Orthopaedic Hospital, Stanmore, UK
  London, England, United Kingdom
• NP

  Nischalan Pillay, MBChB, FRCPath, PhD (he/him/his)

  Associate Clinical Professor
  University College London, Cancer Institute
  London, England, United Kingdom
• SH

  Steve Horvath, PhD

  Altos Labs, Cambridge Institute of Science, Cambridge, UK
  Cambridge, England, United Kingdom
• 

  Stephan Beck, PhD

  Professor of MedicaL Genomics
  Medical Genomics Research Group, University College London, UCL Cancer Institute, London, UK
  London, England, United Kingdom
• 

  Adrienne Margaret Flanagan, MD-PhD (she/her/hers)

  Academic Head of Research Department of Pathology
  University College London, Cancer Institute
  London, England, United Kingdom
• IL

  Iben Lyskjær, PhD

  Department of Molecular Medicine, Aarhus University Hospital, Aarhus, DK
  Aarhus, Nordjylland, Denmark